Reuters logo
BRIEF-Akorn invalidates Durezol patent via inter partes review proceeding
November 28, 2016 / 10:50 PM / in a year

BRIEF-Akorn invalidates Durezol patent via inter partes review proceeding

Nov 28 (Reuters) - Akorn Inc

* On November 22, 2016, patent trial and appeal board ruled in favor of Akorn in its inter partes review proceeding

* PTAB found all claims of 6.1 million patent related to Durezol formulation to be obvious Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below